Skip to content
Search

Latest Stories

Historical films need to be close to reality, cannot fantasise things: Mani Ratnam

The critically-acclaimed director, who is awaiting the release of Ponniyin Selvan II, said one cannot add elements to a period story that are not real.

Historical films need to be close to reality, cannot fantasise things: Mani Ratnam

Filmmaker Mani Ratnam on Tuesday said the objective with historical films should be to stay honest about the events and yet make the story contemporary for the audience.

The critically-acclaimed director, who is awaiting the release of Ponniyin Selvan II, said one cannot add elements to a period story that are not real.


"Whatever film you make, you try to make it as well as you can. But when it is a period drama and when it is historical, you try to go as close as you cannot fantasise about it and add elements that are not real. (You) try to bring it as close to reality as possible.

"This film (is) treated in that fashion and the objective while making (it) was simple, it should look like it is happening now or it should look like we are there next to the characters. So, it was shot, it was put together and performed casually and not like a historical drama so everything added to that," the director told reporters here at the press conference of Ponniyin Selvan 2.

Ratnam also said that he doesn't agree with the phrase "pan-India movie", which gained popularity in the last few years owing to the success of movies such as SS Rajamouli's Baahubali franchise, RRR, Allu Arjun’s Pushpa: The Rise, KGF starring Kannada star Yash and Kantara.

"I absolutely agree. We should take away the word pan-India as it has always been India," the 66-year-old filmmaker said.

Ratnam's two-part Ponniyin Selvan is an adaptation of author Kalki Krishnamurthy's 1955 Tamil novel of the same name. It chronicles the story of the early days of Arulmozhivarman (Jayam Ravi), one of the most powerful kings in the south, who went on to become the great Chola emperor Rajaraja Chola I.

The first part was released in September 2022.

The Tamil language epic marks Ratnam's fourth collaboration with Aishwarya Rai Bachchan after Iruvar, Raavanan, and Guru.

The director said he has always approached Aishwarya whenever he felt she is best suited to play a character in his movies.

"Filmmakers are very very selfish people, absolutely heartless and selfish, the only thing they care for is the film. How much ever I love her (Aishwarya), I will ask her only if I think she is right for the role.

"Every time I have asked her it is because I have believed that she was absolutely right for the role and she has been nice enough to say yes. So, she is not just a lucky charm for me, it is her talent and her personality that was right to portray this character," he said.

Asked about the possibility of making a third part of Ponniyin Selvan, Ratnam said, "Maybe but I don't know who will make it."

Also starring Vikram, Karthi, Jayam Ravi, Trisha, Shobhita Dhulipala, Aishwarya Lekshmi, and Prakash Raj, Ponniyin Selvan II will be released worldwide on Friday in Tamil along with the dubbed versions in Hindi, Kannada, Telugu, and Malayalam.

More For You

Heidi Klum

Heidi and Leni Klum pose together in co-ordinated Intimissimi gowns at the Venice Film Festival

Instagram/heidiklum

Heidi Klum Venice Film Festival look with daughter Leni reignites criticism over mother-daughter lingerie fashion partnership

Highlights:

  • Heidi Klum and daughter Leni walked the Venice Film Festival red carpet in matching corset-style gowns.
  • The supermodel opted for a blush pink silk design, while Leni wore an inky black version.
  • Both gowns were created by Italian lingerie brand Intimissimi, for which they are ambassadors.
  • The mother-daughter duo previously fronted a controversial campaign for the same brand.

Heidi Klum's Venice Film Festival appearances always generate headlines, but this year she doubled the impact by walking the red carpet with her daughter Leni. The pair stunned in co-ordinated gowns from Italian intimates brand Intimissimi, bringing high fashion and red carpet glamour together in one of the festival’s most talked-about moments. Their matching corset silhouettes highlighted the duo’s modelling credentials and added a striking family twist to the opening night of the prestigious event.

Heidi Klum Heidi and Leni Klum pose together in co-ordinated Intimissimi gowns at the Venice Film Festival Instagram/heidiklum

Keep ReadingShow less
Ahaan Panday

Ahaan Panday says years of blind optimism kept him going before Saiyaara

Instagram/ahaanpandayy

Ahaan Panday says Bollywood wronged him and admits he was delusional before 'Saiyaara' broke box office records

Highlights:

  • Ahaan Panday opens up on being ‘wronged’ before his Bollywood debut
  • Actor admits he spent years in ‘blind optimism’ waiting for launch
  • Saiyaara has become the highest-grossing love story in Indian cinema history
  • The Mohit Suri directorial collected £53 million (₹563 crore) worldwide

Bollywood newcomer Ahaan Panday has revealed that he felt “wronged” by people in the industry before finally making his long-awaited debut with Mohit Suri’s Saiyaara. The 27-year-old actor, who comes from the well-known Panday family, said he lived in “blind optimism” for four to five years as projects kept falling through. Despite setbacks, Ahaan maintained that he never became bitter and channelled his struggles into his performance.

Ahaan Panday says years of blind optimism kept him going before Saiyaara Instagram/ahaanpandayy

Keep ReadingShow less
Jio Platforms

Jio Platforms includes India’s largest telecom operator, Reliance Jio Infocomm, with more than 500 million users. (Photo: Reuters)

Reuters

Jio IPO planned for mid-2026, AI unit announced with Meta and Google

RELIANCE Industries plans to take its telecom and digital arm, Jio Platforms, public by mid-2026, chairman Mukesh Ambani said on Friday. The announcement sets a new timeline for the long-awaited IPO of a business analysts value at over $100 billion.

At its annual general meeting (AGM), Reliance also announced the launch of an artificial intelligence unit in partnership with Google and Meta.

Keep ReadingShow less
Sony next console

The top model could match the PS5 Pro at around £699.99

Nintendo

Sony’s next console could be both handheld and dockable, claim rumours

Highlights:

  • Reports suggest Sony is planning three versions of its next console
  • One model, codenamed Canis, could function as both a handheld and a docked console, similar to Nintendo Switch
  • The flagship version, Orion, is expected to be the main high-spec console
  • Pricing speculation indicates the top model could match the PS5 Pro at around £699.99

Fresh rumours claim Sony is preparing a dockable handheld version of its next-generation console, the PlayStation 6. The device, reportedly codenamed Canis, is said to target the same hybrid market as Nintendo’s Switch and the expected Switch 2.

Details of the rumour

The information comes from YouTube channel Moore’s Law is Dead (via Push Square), which suggests Sony will release three versions of the PS6:

Keep ReadingShow less
Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less